AiCuris
Germany - WuppertalBiotechnology
Focus: AiCuris is a Germany-based biotechnology company specializing in anti-infective therapies, focused on viral infectious diseases with a clinical-stage pipeline. Acquired by Asahi Kasei in April 2026, the company operates as a subsidiary within a larger pharmaceutical and materials conglomerate.
Profile data last refreshed 5h ago · AI intelligence enriched 4d ago
Funding Stage
PUBLIC
Open Jobs
2
Should You Work at AiCuris?
AI assessmentAiCuris offers meaningful clinical upside in a niche viral disease area with Phase 3 momentum, but limited scale and hiring suggest it's best suited for scientists comfortable in small, acquisition-integrated teams rather than those seeking rapid internal advancement.
Why Work Here
- Lead candidate pritelivir in Phase 3 for HSV infection with 5 active trials represents a near-term regulatory catalyst and clinical validation opportunity.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Study to Assess Management and Outcomes of Hospitalised Patients With Complicated UTI (RESCUING)
Urinary Tract InfectionsClinical Trials (1)
NCT02641015Study to Assess Management and Outcomes of Hospitalised Patients With Complicated UTI (RESCUING)
N/AHelp build intelligence for AiCuris
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.